199 related articles for article (PubMed ID: 23371439)
1. Maternal serum protein profile and immune response protein subunits as markers for non-invasive prenatal diagnosis of trisomy 21, 18, and 13.
Narasimhan K; Lin SL; Tong T; Baig S; Ho S; Sukumar P; Biswas A; Hahn S; Bajic VB; Choolani M
Prenat Diagn; 2013 Mar; 33(3):223-31. PubMed ID: 23371439
[TBL] [Abstract][Full Text] [Related]
2. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
[TBL] [Abstract][Full Text] [Related]
3. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
4. Two-Dimensional Differential Gel Electrophoresis to Identify Protein Biomarkers in Amniotic Fluid of Edwards Syndrome (Trisomy 18) Pregnancies.
Hsu TY; Lin H; Hung HN; Yang KD; Ou CY; Tsai CC; Cheng HH; Chung SH; Cheng BH; Wong YH; Chou AK; Hsiao CC
PLoS One; 2016; 11(1):e0145908. PubMed ID: 26752631
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
[TBL] [Abstract][Full Text] [Related]
6. [Noninvasive prenatal diagnosis of trisomy 21, 18 and 13 using cell-free fetal DNA].
Gorzelnik K; Bijok J; Zimowski JG; Jakiel G; Roszkowski T
Ginekol Pol; 2013 Aug; 84(8):714-9. PubMed ID: 24191506
[TBL] [Abstract][Full Text] [Related]
7. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
8. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES].
Chaveeva P; Yankova M; Stratieva V; Dimitrov I; Shterev A
Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651
[TBL] [Abstract][Full Text] [Related]
9. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.
Nicolaides KH; Syngelaki A; Poon LC; Gil MM; Wright D
Fetal Diagn Ther; 2014; 35(3):185-92. PubMed ID: 24192489
[TBL] [Abstract][Full Text] [Related]
10. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
Langlois S; Duncan A; ;
J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
[TBL] [Abstract][Full Text] [Related]
11. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.
Porreco RP; Garite TJ; Maurel K; Marusiak B; ; Ehrich M; van den Boom D; Deciu C; Bombard A
Am J Obstet Gynecol; 2014 Oct; 211(4):365.e1-12. PubMed ID: 24657131
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum analyte screening for fetal aneuploidy.
Chasen ST
Clin Obstet Gynecol; 2014 Mar; 57(1):182-8. PubMed ID: 24488056
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
[TBL] [Abstract][Full Text] [Related]
15. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
Wagner AJ; Mitchell ME; Tomita-Mitchell A
Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
[TBL] [Abstract][Full Text] [Related]
16. Detection of fetal chromosomal anomalies: does nuchal translucency measurement have added value in the era of non-invasive prenatal testing?
Lichtenbelt KD; Diemel BD; Koster MP; Manten GT; Siljee J; Schuring-Blom GH; Page-Christiaens GC
Prenat Diagn; 2015 Jul; 35(7):663-8. PubMed ID: 25754604
[TBL] [Abstract][Full Text] [Related]
17. IONA test for first-trimester detection of trisomies 21, 18 and 13.
Poon LC; Dumidrascu-Diris D; Francisco C; Fantasia I; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):184-7. PubMed ID: 26387684
[TBL] [Abstract][Full Text] [Related]
18. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma.
Kolialexi A; Tsangaris GT; Papantoniou N; Anagnostopoulos AK; Vougas K; Bagiokos V; Antsaklis A; Mavrou A
Prenat Diagn; 2008 Aug; 28(8):691-8. PubMed ID: 18551720
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience from Thailand: noninvasive prenatal testing as screening tests for trisomies 21, 18 and 13 in 4736 pregnancies.
Manotaya S; Xu H; Uerpairojkit B; Chen F; Charoenvidhya D; Liu H; Petcharaburanin N; Liu Y; Tang S; Wang X; Dansakul S; Thomsopa T; Gao Y; Zhang H; Xu H; Jiang H
Prenat Diagn; 2016 Mar; 36(3):224-31. PubMed ID: 26748603
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.
Nagalla SR; Canick JA; Jacob T; Schneider KA; Reddy AP; Thomas A; Dasari S; Lu X; Lapidus JA; Lambert-Messerlian GM; Gravett MG; Roberts CT; Luthy D; Malone FD; D'Alton ME
J Proteome Res; 2007 Apr; 6(4):1245-57. PubMed ID: 17373838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
